Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2008
11/18/2008US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing
11/18/2008US7452913 Patterns of enzyme inhibitors formed by dissolving compounds and isolation by precipitation
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/13/2008WO2008137805A1 5-lipoxygenase-activating protein (flap) inhibitors
11/13/2008WO2008137609A1 5-lipoxygenase-activating protein (flap) inhibitors
11/13/2008WO2008137027A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008136017A1 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
11/13/2008WO2008135442A1 Heterocyclic compounds and their use as pesticides
11/13/2008WO2008113760A3 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
11/13/2008WO2008083130A3 Amorphous and crystalline form a of carvedilol phosphate
11/13/2008WO2008044243A9 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
11/13/2008WO2008017079A3 Dyes and precursors and conjugates thereof
11/13/2008WO2007056279A3 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
11/13/2008US20080281102 Methods and Compounds For Preparing Cc-1065 Analogs
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280966 Emesis, urinary incontinence, depression, and anxiety; substance P inhibitors; 5-{1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindole
11/13/2008US20080280923 1-Benzylindole-2-Carboxamide Derivatives
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280895 5-Amino-4-Hydroxy-7-(1H-Indolmethyl)-8-Methylnonamide Derivatives as Renin Inhibitors for the Treatment of Hypertension
11/13/2008US20080280891 effective against a broad range of cancers, especially leukemia, non-small cell lung and colon; (6-chloropyridin-3-yl)-[3-hydroxy-5-(1H-indol-4-yl)-phenyl]-methanone; antimitotic agents that can block cell cycle progression
11/13/2008US20080279776 Photosensitizers and MRI Enhancers
11/13/2008US20080279769 Enzyme Inhibitor Imaging Agents
11/13/2008CA2686232A1 5-lipoxygenase-activating protein (flap) inhibitors
11/13/2008CA2685215A1 Compounds and methods useful for treating asthma and allergic inflammation
11/13/2008CA2683821A1 Heterocyclic compounds and their use as pesticides
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1990051A1 Combinations of SSRI and estrogenic agents
11/12/2008EP1989182A1 Crystalline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it
11/12/2008EP1989180A1 Modified amino acids
11/12/2008EP1751138B9 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2008EP1703905B1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
11/12/2008EP1658067B1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
11/12/2008EP1628977B1 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES
11/12/2008EP1624868B1 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl]phenyl derivatives as beta2 agonists
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008CN101305041A Photolatent systems
11/12/2008CN101304973A Methods of modulating neurotrophin-mediated activity
11/12/2008CN101302187A Production process of high-quality carbazol and anthracene
11/12/2008CN101302186A (2E, 4Z)-4-(3-oxo isoindole-1-alkenyl)-2-ethyl crotonate and synthetic method thereof
11/12/2008CN101302185A Preparation of trandolaprilat
11/12/2008CN101302184A Indoline sulfanilamide compound
11/12/2008CN101302183A Preparation of 5-substituted-1-(3-hydroxypropyl)-7-carbamyl indoline
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN100432071C Substituted 1H-indole-2-ketone compound and its preparation method and uses
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432052C Synthetic method for methoxy indole
11/12/2008CN100432051C Coupling product between tryptamine and alpha-amino acid, process for its prepn. as well as its application in neurocosmetic field
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449489 e.g. isopropyl [({2-[5-[2-(2-azabicyclo[2.2.2]oct-2-yl)- 1,1-dimethyl-2-oxoethyl]-2-(3,5-dimethylphenyl)-1H-indol-3-yl]propyl }amino)(3-pyridin-4-ylpyrrolidin-1-yl)methylene]carbamate; gonadotrophin releasing hormone antagonists; anticarcinogenic agent; breast, prostate, uretus cancer
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/11/2008US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases
11/11/2008US7449459 Inhibitors of soluble adenylate cyclase
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/11/2008US7449447 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
11/06/2008WO2008134679A1 Inhibitors of iap
11/06/2008WO2008134047A1 Methods of treating hypertension
11/06/2008WO2008132103A1 Pentaphenylene derivatives as photosensitizers in solar cells
11/06/2008WO2008131972A1 Arylmethylen substituted n-acyl-gamma-aminoalcohols
11/06/2008WO2008042571A3 Substituted indole compounds
11/06/2008WO2008020306A3 Isoindole derivatives
11/06/2008US20080275224 Cyanoborate, Fluoroalkylphosphate, Fluoroalkylborate or Imide Dyes
11/06/2008US20080275102 And 3-oximidoindole derivatives; cannabinoid receptor antagonists; cardiovascular, gastrointestinal, autoimmune, and neurodegenerative disorders; obesity, infections; antidiabetic and antiallergen agents; acylation, oximination
11/06/2008US20080275101 Citrate and phosphate salts of 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide for treatment of protein kinase related disorders; crystallization; pharmacokinetics
11/06/2008US20080275083 2,3,4,9-tetrahydro-1h-carbazoles
11/06/2008US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia
11/06/2008US20080275017 Aromatic sulfenates for type i phototherapy
11/06/2008US20080275016 For drug resistant cancers; antiinflammatory agents;degenerative or vascular diseases; blocking nitrogen oxide so growth of tumors is suppressed
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080274980 Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation
11/06/2008US20080274907 Fluorogenic ph sensitive dyes and their method of use
11/06/2008US20080274893 Spirocyclic 3-Phenyl-3substituted-4-Ketolactams and-lactones
11/06/2008CA2683392A1 Inhibitors of iap
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1988076A1 Amide derivative or salt thereof
11/05/2008EP1987828A1 salts of perindopril and their use in the therapy of hypertension
11/05/2008EP1986999A1 Benzoisoindole derivatives and their use as ep4 receptor ligands
11/05/2008EP1986998A1 Metabotropic glutamate receptor-potentiating soindolones
11/05/2008EP1663970B1 Matrix metalloproteinase inhibitors
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008CN101300241A Piperazine derivatives as antimalarial agents
11/05/2008CN101300230A N-(hetero) aryl indole derivatives as pesticides
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
11/05/2008CN100430444C Cyanine compounds, optical recording materials and optical recording media
11/05/2008CN100430405C Processes for preparing calcium salt forms of statins
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446212 Polymethine ethers
11/04/2008US7446129 Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, then react resulting nucleophilic PDE4 inhibitor with benzylating agent, e.g., benzyl bromide; no emetogenic side effects
11/04/2008US7446123 Azabicyclo derivatives as muscarinic receptor antagonists
11/04/2008US7446118 depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; 5-(3-Methylamino-1H-phenyl-propyl)-1H-indole-3-carbonitrile
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/04/2008US7446103 N-[4-(3-Piperidin-1-ylpropoxy)-benzoyl]-5-fluoroisoindoline; Alzheimer's disease; cognition enhancers; amidation
11/04/2008US7445767 Using water soluble dyes; contrast media for fluorescence
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 458